Organicell Financial Statements From 2010 to 2022

OCEL
 Stock
  

USD 0.0403  0.0012  2.89%   

Organicell Regenerative financial statements provide useful quarterly and yearly information to potential Organicell Regenerative Medicine investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Organicell Regenerative financial statements helps investors assess Organicell Regenerative's valuation, profitability, and current liquidity needs.
Organicell Regenerative Medicine does not presently have any trending fundamental ratios for analysis.
.
  
Check Organicell Regenerative financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Organicell main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Organicell financial statements analysis is a perfect complement when working with Organicell Regenerative Valuation or Volatility modules. It can also supplement various Organicell Regenerative Technical models . Please check the analysis of Organicell Regenerative Correlation against competitors.

Organicell Working Capital Analysis

Organicell Regenerative's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Working Capital 
 = 
Current Assets 
Current Liabilities 
More About Working Capital | All Equity Analysis

Current Organicell Regenerative Working Capital

    
  (520 K)  
Most of Organicell Regenerative's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Organicell Regenerative Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Compare to competition

Based on the company's disclosures, Organicell Regenerative Medicine has a Working Capital of (520,000). This is 100.12% lower than that of the Healthcare sector and 100.1% lower than that of the Biotechnology industry. The working capital for all United States stocks is 100.04% higher than that of the company.

Organicell Regenerative Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Organicell Regenerative's current stock value. Our valuation model uses many indicators to compare Organicell Regenerative value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Organicell Regenerative competition to find correlations between indicators driving Organicell Regenerative's intrinsic value. More Info.
Organicell Regenerative Medicine is considered to be number one stock in profit margin category among related companies. It is considered to be number one stock in shares owned by insiders category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Organicell Regenerative by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Organicell Regenerative's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Organicell Regenerative's earnings, one of the primary drivers of an investment's value.

About Organicell Regenerative Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Organicell Regenerative income statement, its balance sheet, and the statement of cash flows. Organicell Regenerative investors use historical funamental indicators, such as Organicell Regenerative's revenue or net income, to determine how well the company is positioned to perform in the future. Although Organicell Regenerative investors may use each financial statement separately, they are all related. The changes in Organicell Regenerative's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Organicell Regenerative's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Organicell Regenerative Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Organicell Regenerative. Please read more on our technical analysis and fundamental analysis pages.
Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida. Organicell Regenerative operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 22 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Organicell Regenerative without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Commodity Channel Index Now

   

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Organicell Regenerative using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check the analysis of Organicell Regenerative Correlation against competitors. Note that the Organicell Regenerative information on this page should be used as a complementary analysis to other Organicell Regenerative's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Organicell OTC Stock analysis

When running Organicell Regenerative price analysis, check to measure Organicell Regenerative's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organicell Regenerative is operating at the current time. Most of Organicell Regenerative's value examination focuses on studying past and present price action to predict the probability of Organicell Regenerative's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Organicell Regenerative's price. Additionally, you may evaluate how the addition of Organicell Regenerative to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Is Organicell Regenerative's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organicell Regenerative. If investors know Organicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organicell Regenerative listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Organicell Regenerative is measured differently than its book value, which is the value of Organicell that is recorded on the company's balance sheet. Investors also form their own opinion of Organicell Regenerative's value that differs from its market value or its book value, called intrinsic value, which is Organicell Regenerative's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organicell Regenerative's market value can be influenced by many factors that don't directly affect Organicell Regenerative's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organicell Regenerative's value and its price as these two are different measures arrived at by different means. Investors typically determine Organicell Regenerative value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organicell Regenerative's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.